TACSTD2 and colorectal carcinoma: H3K18 lactylation depletion in vitro markedly suppressed TROP2‐driven pro‐metastatic capacities in CRC cells, including proliferation (Figure 4D and E), tumourigenicity (Figure 4F and G) and motility (Figure 4H and I).